Siren »

Fulcrum Therapeutics shares owned by Siren

Quarter-by-quarter ownership of Fulcrum Therapeutics (FULC) shares owned by Siren from 13F filings

Historical chart of Siren investment in Fulcrum Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fulcrum Therapeutics held by Siren consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fulcrum Therapeutics by Siren

Quarter filed Position value Share count Share price at filing
2026-03-31 $18M 2.4M 7.67
2025-12-31 $22M 2.0M 11.31

More positions owned by Siren

Scholar Rock Hldg Corp (SRRK)
Kymera Therapeutics (KYMR)
Erasca (ERAS)
Edgewise Therapeutics (EWTX)
BeOne Medicines Sponsored Ads (ONC)
Tango Therapeutics (TNGX)
Bicara Therapeutics (BCAX)
Revolution Medicines (RVMD)
Arrowhead Pharmaceuticals (ARWR)
Veradermics Common Stock (MANE)
Xenon Pharmaceuticals (XENE)
Olema Pharmaceuticals (OLMA)
Crinetics Pharmaceuticals In (CRNX)
Lexicon Pharmaceuticals Com New (LXRX)
Cogent Biosciences (COGT)

View all positions for Siren

Top funds holding Fulcrum Therapeutics

Suvretta Capital Management
RA Capital Management
BlackRock
TCG Crossover Management
Braidwell
Nantahala Capital Management
Vanguard Capital Management
Siren
First Turn Management
Balyasny Asset Management
Point72 Asset Management
Jones Hill Capital
D. E. Shaw & Co
State Street Corporation
Geode Capital Management

View all funds holding Fulcrum Therapeutics